These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2708546)

  • 21. Treatment of essential hypertension and hypertension associated with renal impairment with pinacidil: a new vasodilator.
    Breen EG; Mulhall D; Keogh JA
    Eur J Clin Pharmacol; 1985; 28(4):381-6. PubMed ID: 4029244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introductory remarks: symposium on pinacidil: potassium channel openers in the treatment of hypertension.
    Weston AH
    Drugs; 1988; 36 Suppl 7():1-3. PubMed ID: 3254828
    [No Abstract]   [Full Text] [Related]  

  • 23. Lipid and apolipoprotein levels during therapy with pinacidil combined with hydrochlorothiazide.
    Corder CN; Goldberg MR; Alaupovic PA; Price MD; Furste SS
    Eur J Clin Pharmacol; 1992; 42(1):65-70. PubMed ID: 1541318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antihypertensive effect of pinacidil versus prazosin in mild to moderate hypertensive patients seen in general practice.
    Sterndorff B; Johansen P
    Acta Med Scand; 1988; 224(4):329-36. PubMed ID: 3188983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition of [14C]pinacidil in humans.
    DeLong AF; Oldham SW; DeSante KA; Nell G; Henry DP
    J Pharm Sci; 1988 Feb; 77(2):153-6. PubMed ID: 3361430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pinacidil, a new vasodilator: pharmacokinetics and pharmacodynamics of a new retarded release tablet in essential hypertension.
    Carlsen JE; Kardel T; Jensen HA; Tangø M; Trap-Jensen J
    Eur J Clin Pharmacol; 1983; 25(4):557-61. PubMed ID: 6653652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actions of pinacidil at a reduced potassium concentration: a direct cardiac effect possibly involving the ATP-dependent potassium channel.
    Chi L; Black SC; Kuo PI; Fagbemi SO; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):179-90. PubMed ID: 7679150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chiral recognition of pinacidil and its 3-pyridyl isomer by canine cardiac and smooth muscle: antagonism by sulfonylureas.
    Steinberg MI; Wiest SA; Zimmerman KM; Ertel PJ; Bemis KG; Robertson DW
    J Pharmacol Exp Ther; 1991 Jan; 256(1):222-9. PubMed ID: 1899116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pinacidil: potassium channel openers in the treatment of hypertension. Proceedings of a symposium. Copenhagen, 10-11 March, 1988.
    Drugs; 1988; 36 Suppl 7():1-98. PubMed ID: 3254829
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute hemodynamic effects of pinacidil in hypertensive patients with and without propranolol pretreatment.
    Stone CK; Wellington KL; Willick A; Sullebarger JT; Liang CS
    J Clin Pharmacol; 1991 Apr; 31(4):333-41. PubMed ID: 2037705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic effects of direct vasodilation (pinacidil), alpha-adrenergic blockade (prazosin) and angiotensin-converting enzyme inhibition (captopril) in systemic hypertension.
    Izzo JL; Licht MR; Smith RJ; Larrabee PS; Radke KJ; Kallay MC
    Am J Cardiol; 1987 Aug; 60(4):303-8. PubMed ID: 2887102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pinacidil. Preclinical investigations.
    Ahnfelt-Rønne I
    Drugs; 1988; 36 Suppl 7():4-9. PubMed ID: 3076134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Potassium channel activators. Perspectives in the treatment of arterial hypertension].
    Giudicelli JF; Richer C; Berdeaux A
    Presse Med; 1991 Jan; 20(2):75-81. PubMed ID: 1825708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of two K+ channel openers, aprikalim and pinacidil, on hypoxic pulmonary vasoconstriction.
    Dumas JP; Dumas M; Sgro C; Advenier C; Giudicelli JF
    Eur J Pharmacol; 1994 Sep; 263(1-2):17-23. PubMed ID: 7821349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of pinacidil on detrusor instability in men with bladder outlet obstruction.
    Hedlund H; Mattiasson A; Andersson KE
    J Urol; 1991 Nov; 146(5):1345-7. PubMed ID: 1942288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial effects of pinacidil on blood lipids: comparisons with prazosin and placebo in patients with hypertension. Pinacidil-Prazosin and Pinacidil-Placebo Research Groups, Lilly Research Laboratories.
    Rockhold FW; Goldberg MR; Thompson WL
    J Lab Clin Med; 1989 Dec; 114(6):646-54. PubMed ID: 2687423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary evaluation of pinacidil in hypertension.
    Ramsay LE; Freestone S
    Br J Clin Pharmacol; 1983 Sep; 16(3):336-8. PubMed ID: 6626426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of pinacidil and nifedipine in the treatment of arterial hypertension.
    Jürgensen HJ
    Drugs; 1988; 36 Suppl 7():67-9. PubMed ID: 3076138
    [No Abstract]   [Full Text] [Related]  

  • 39. Activation of large-conductance potassium channels in pregnant human myometrium by pinacidil.
    Khan RN; Morrison JJ; Smith SK; Ashford ML
    Am J Obstet Gynecol; 1998 May; 178(5):1027-34. PubMed ID: 9609579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of activation of ATP-dependent potassium channels with (-)-pinacidil and (-)-3-pyridyl pinacidil on infarct size in a canine model of ischemia-reperfusion injury.
    Smallwood JK; Schelm JA; Bemis KG; Simpson PJ
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):731-43. PubMed ID: 7506326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.